It was revealed this past July by the United States Anti-Doping Agency (USADA) that UFC heavyweight Daniel Omielanczuk had potentially failed a drug test.
USADA announced on February 6 that Omielanczuk accepted a no fault finding for the violation because it was determined by USADA that ingested an illegal substance without fault or negligence according to World Anti-Doping Agency (WADA) guidance.
Here is the statement issued by USADA:
“During USADA’s investigation of the case, Omielanczuk presented evidence establishing that his use of meldonium was limited to a three-week span, from mid-August to early September 2015,” the USADA statement reads. “Omielanczuk and his advisors confirmed that Omielanczuk did not resume his use of the substance after September 2015 because they became aware that the substance would be added to the WADA Prohibited List in 2016, and subsequently banned under the UFC Anti-Doping Program. After a thorough review of the case, USADA concluded that the extremely low meldonium concentration in the athlete’s urine sample, combined with the available documentary evidence and the athlete’s explanation of use, was consistent with ingestion prior to the substance being officially prohibited on January 1, 2016.”
Omielanczuk is scheduled to face Timothy Johnson at UFC Fight Night 107, which takes place on Saturday, March 18.